This conference call transcript was computer generated and almost certianly contains errors. This transcript is provided for information purposes only.EarningsCall, LLC makes no representation about the accuracy of the aforementioned transcript, and you are cautioned not to place undue reliance on the information provided by the transcript.
9/26/2023
Operator
and welcome to the METRA Half Year Results 2023. My name is Jess, and I'll be your coordinator for today's event. Please note, this call is being recorded, and for the duration of the call, your lines will be on listen only. However, there will be the opportunity to ask questions. This can be done by pressing star 1 on your telephone keypad to register your question at any time. If at any point you require assistance, please press star zero and you'll be connected to an operator. I will now hand over to your host, Alex Sokolovsky, Head of Investor Relations, to begin today's call. Thank you.
Jess
Thank you, operator. And welcome, ladies and gentlemen, to the conference call on Mithra Pharmaceuticals financial results for the first six months of 2023. I'm Alex Sokolovsky, Head of Investor Relations for Mithra. Today's call is being recorded and a replay of this webcast and today's presentation slides will be made available later today on Mitra's website. I'd like to call your attention to the forward-looking statements before I provide an overview of our agenda. Today's call contains forward-looking statements which are made based on information currently available to Mitra and certain assumptions considered reasonable as of the date of this material. These forward-looking statements are not guarantees of future performance and actual operating results may differ substantially due to a number of factors. Today, our CEO, David Horn-Solomon, will make some introductory remarks before our CFO, Christophe Marchal, will guide us through the financial results highlights. Then David will cover the select operational highlights year to date. We will then hold the Q&A session before closing the call. David, the floor is yours.
Alex Sokolovsky
Thank you very much, Alex, and welcome to everyone. I'm David Solomon. I'm the CEO of Mithra Pharmaceuticals, and I'm really glad you could all take the time today to join us for our 2023 half-year financial results. We've accomplished a lot already in this period. Some of the events we're going to report happened before I joined as CEO, but really under my leadership and with our management team, we're working hard to create what we now call Mithra 2.0, which is a company that will have strong results based on our assets, and we hope and
Disclaimer